PHARMACIA
Scope & Guideline
Advancing pharmaceutical knowledge for a healthier tomorrow.
Introduction
Aims and Scopes
- Pharmacological Research and Drug Development:
The journal publishes studies on the discovery and development of new pharmaceutical compounds, including their synthesis, characterization, and evaluation of biological activities. - Clinical Pharmacology and Therapeutics:
Research focusing on the clinical aspects of drug therapy, including efficacy, safety, pharmacokinetics, and pharmacodynamics in various patient populations. - Natural Products and Phytochemistry:
The exploration of natural products for their pharmacological potential, including studies on herbal medicines, phytochemicals, and traditional healing practices. - Formulation Science and Drug Delivery Systems:
Innovations in drug formulation and delivery methods, emphasizing the development of novel drug delivery systems such as nanoparticle-based therapies and transdermal patches. - Public Health and Pharmacoeconomics:
Research addressing public health issues, medication adherence, and economic evaluations of pharmacological interventions to optimize healthcare outcomes. - Regulatory Affairs and Pharmaceutical Legislation:
Studies related to regulatory policies, drug approval processes, and the impact of pharmaceutical legislation on drug accessibility and safety.
Trending and Emerging
- Artificial Intelligence and Machine Learning in Drug Development:
The integration of AI and machine learning methodologies for drug discovery and development, predictive modeling of drug interactions, and optimization of therapeutic strategies is increasingly featured. - Nanotechnology in Medicine:
Research on nanomedicine, including the use of nanoparticles for targeted drug delivery, enhanced bioavailability, and reduced toxicity, is on the rise. - Pharmacogenomics and Personalized Medicine:
Studies examining genetic variations that affect drug metabolism and response, supporting the move towards personalized pharmacotherapy tailored to individual patient profiles. - Telepharmacy and Digital Health Solutions:
The rise of telepharmacy and digital health technologies, especially post-COVID-19, reflects a growing interest in remote patient monitoring and medication management. - Antimicrobial Resistance and Stewardship:
Research addressing the challenges of antimicrobial resistance, including stewardship programs and the development of novel antimicrobials, is increasingly relevant. - Integrative Approaches in Chronic Disease Management:
Emerging studies focus on integrative methods for managing chronic diseases, combining pharmacological treatments with lifestyle interventions and complementary therapies.
Declining or Waning
- Traditional Medicine Studies:
Research related to traditional medicine practices and their efficacy has decreased, possibly due to a shift towards more evidence-based and clinical trial-oriented research. - Chemical Synthesis of Known Compounds:
The focus on the synthesis of already established compounds, rather than novel entities, has waned as the field increasingly prioritizes innovative drug discovery. - Basic Laboratory Studies:
Basic laboratory research without direct clinical implications is less prevalent, as there is a growing demand for studies that translate findings into clinical applications. - Single-Site Clinical Trials:
There has been a noticeable decline in studies that focus on single-site clinical trials, as multi-center and global studies gain preference for their broader applicability and relevance. - In Vitro Studies Without Clinical Correlation:
The number of purely in vitro studies lacking a clear clinical correlation has decreased, as the journal emphasizes research that can demonstrate practical applications in patient care.
Similar Journals
Future Journal of Pharmaceutical Sciences
Transforming Research into Real-World Pharmaceutical ApplicationsThe Future Journal of Pharmaceutical Sciences, published by Springer, stands as a vital resource in the realm of pharmaceutical research and innovation. Recognized for its open access initiative since 2015, this journal promotes extensive dissemination of cutting-edge discoveries, fostering collaboration among researchers, industry professionals, and students alike. With an ISSN of 2314-7245 and an E-ISSN of 2314-7253, it aims to bridge the gap between laboratory research and practical applications in the pharmaceutical sciences. Although specific metrics like HIndex and Scopus ranks are currently unavailable, the journal's commitment to high-quality, peer-reviewed content positions it as a promising platform for advancing pharmaceutical science. By engaging with this journal, contributors and readers can participate in the vibrant discourse shaping the future of drug development, therapeutic strategies, and healthcare solutions.
Ars Pharmaceutica
Pioneering research that shapes the future of pharmacy.Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.
Frontiers in Pharmacology
Pioneering discoveries in pharmacokinetics, toxicology, and beyond.Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
Empowering researchers to shape the future of pharmaceutical sciences.Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.
International Journal of Pharmaceutical Investigation
Exploring Breakthroughs in Pharmaceutical ResearchInternational Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.
Istanbul Journal of Pharmacy
Transforming ideas into impactful pharmaceutical solutions.Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Advancing the Frontiers of Biomedicine and Drug DevelopmentBIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.
Indonesian Journal of Pharmacy
Empowering research in pharmacy and pharmacology worldwide.Indonesian Journal of Pharmacy (ISSN: 2338-9486; E-ISSN: 2338-9427), published by UNIV GADJAH MADA, FAC FARMASI, stands as a significant platform for disseminating pioneering research in the field of pharmacy and pharmacology. Since its transition to an Open Access format in 2011, the journal has enhanced its visibility and accessibility, catering to a global audience of researchers, practitioners, and students. With a commendable Q3 category ranking in Pharmaceutical Science, Pharmacology, and Pharmacy for 2023, along with its respectable Scopus ranks, it provides valuable insights and advancements in the pharmaceutical sciences, particularly relevant to the Indonesian context and beyond. The journal not only supports the academic community but also contributes to the enhancement of healthcare practices through rigorous peer-reviewed publications. By fostering knowledge exchange and collaboration, the Indonesian Journal of Pharmacy aims to play a pivotal role in advancing research and development in pharmacy-related disciplines.
International Journal of Pharmacology
Connecting Laboratory Discoveries to Clinical PracticeWelcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.
Journal of Reports in Pharmaceutical Sciences
Innovating Drug Development Through Groundbreaking Research.Journal of Reports in Pharmaceutical Sciences is a pivotal publication in the realm of pharmaceutical research, disseminating innovative findings that cater to the evolving landscape of pharmacology, toxicology, and biomedical engineering. Published by Wolters Kluwer Medknow Publications, the journal serves as a bridge for scholars and practitioners aiming to enhance their understanding of drug development, therapeutic advances, and biopharmaceutical technologies. With an ISSN of 2322-1232 and E-ISSN 2322-5106, it has established its relevance from 2012 to 2022, occupying notable quartile rankings, including Q3 in Pharmacology, Toxicology, and Pharmaceutics. Despite being categorized in Q4 in some areas, the journal's commitment to quality research ensures it remains a respected platform for disseminating significant insights. Researchers, professionals, and students alike will find this journal an indispensable resource for staying updated on critical advancements in pharmaceutical sciences, making it a go-to source for impactful studies that shape industry practices and academic inquiries.